EGF treatment also increases the basal ECAR in glioblastoma cells (Li et al., 2016), as well as the lactate production (Jung et al., 2019; Lim et al., 2016) and both basal and maximal ECAR in breast cancer cells (Lim et al., 2016). This evidence concerns the gene EGF and breast cancer.